Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
Globe Newswire (Tue, 12-May 4:06 PM ET)
Stereotaxis Announces First MAGiC Procedures in the United States
Globe Newswire (Wed, 22-Apr 7:58 AM ET)
Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026
Globe Newswire (Tue, 21-Apr 9:01 AM ET)
Stereotaxis Announces Definitive Agreement to Acquire Robocath
Globe Newswire (Wed, 15-Apr 7:00 AM ET)
Stereotaxis Announces FDA Clearance and Launch of Synchrony System
Globe Newswire (Mon, 6-Apr 8:06 AM ET)
Stereotaxis Reports 2025 Full Year Financial Results
Globe Newswire (Mon, 9-Mar 4:01 PM ET)
Market Chameleon (Tue, 6-Jan 5:33 AM ET)
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Stereotaxis trades on the AMEX stock market under the symbol STXS.
As of June 4, 2026, STXS stock price climbed to $1.88 with 275,453 million shares trading.
STXS has a beta of 1.56, meaning it tends to be more sensitive to market movements. STXS has a correlation of 0.16 to the broad based SPY ETF.
STXS has a market cap of $183.75 million. This is considered a Micro Cap stock.
Last quarter Stereotaxis reported $6 million in Revenue and -$.06 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.01.
In the last 3 years, STXS traded as high as $3.59 and as low as $1.33.
The top ETF exchange traded funds that STXS belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
STXS has underperformed the market in the last year with a price return of -17.9% while the SPY ETF gained +28.2%. STXS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.1% and +1.6%, respectively, while the SPY returned +11.5% and +2.1%, respectively.
STXS support price is $1.77 and resistance is $1.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that STXS shares will trade within this expected range on the day.